PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q2 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,141 | +119.0% | 47,345 | -4.1% | 0.00% | 0.0% |
| Q4 2022 | $521 | -99.7% | 49,380 | +37.4% | 0.00% | – |
| Q3 2022 | $161,000 | -16.6% | 35,933 | -25.7% | 0.00% | – |
| Q2 2022 | $193,000 | +11.6% | 48,366 | +103.8% | 0.00% | – |
| Q1 2022 | $173,000 | +183.6% | 23,737 | +115.5% | 0.00% | – |
| Q4 2021 | $61,000 | -79.1% | 11,013 | -68.6% | 0.00% | – |
| Q3 2021 | $292,000 | -11.5% | 35,067 | -10.5% | 0.00% | – |
| Q2 2021 | $330,000 | +164.0% | 39,177 | +430.0% | 0.00% | – |
| Q4 2020 | $125,000 | -38.4% | 7,392 | -53.3% | 0.00% | – |
| Q3 2020 | $203,000 | +24.5% | 15,842 | +36.3% | 0.00% | – |
| Q2 2020 | $163,000 | +162.9% | 11,619 | +71.1% | 0.00% | – |
| Q1 2020 | $62,000 | -38.6% | 6,792 | -0.5% | 0.00% | – |
| Q4 2019 | $101,000 | +114.9% | 6,824 | -1.6% | 0.00% | – |
| Q3 2019 | $47,000 | – | 6,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |